Collplant Biotechnologies Ltd (NASDAQ:CLGN)
| 12.00 Delayed Data As of 3:59pm ET |  +0.41 / +3.54%Today’s Change | 4.27 Today|||52-Week Range 14.77 | +43.71% Year-to-Date |
Latest CLGN News | Press Releases
No recent news for Collplant Biotechnologies Ltd.
Today’s Trading
| Previous close | 11.59 |
| Today’s open | 12.00 |
| Day’s range | 12.00 - 12.15 |
| Volume | 608 |
| Average volume (3 months) | 26,285 |
| Market cap | $132.5M |
Data as of 3:59pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -5,700.00% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +154.86% |
| P/E ratio | NM |
| Price/Sales | 12.52 |
| Price/Book | 2.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENLVEnlivex Therapeutics... | +0.03 | +0.67% |
| VANIVivani Medical Inc | -0.06 | -4.51% |
| APTAlpha Pro Tech Ltd | +0.11 | +2.57% |
| RWLKRewalk Robotics Ltd | -0.00 | -0.08% |
Data as of 3:59pm ET, 02/07/2023
Financials
| Next reporting date | March 23, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $15.6M |
| Annual profit (last year) | $237.0K |
| Net profit margin | 1.52% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Rehovot, Tel Aviv |
Forecasts
